Always one step ahead: How pathogenic bacteria use the type III secretion system to manipulate the intestinal mucosal immune system

The intestinal immune system and the epithelium are the first line of defense in the gut. Constantly exposed to microorganisms from the environment, the gut has complex defense mechanisms to prevent infections, as well as regulatory pathways to tolerate commensal bacteria and food antigens. Intestinal pathogens have developed strategies to regulate intestinal immunity and inflammation in order to establish or prolong infection. The organisms that employ a type III secretion system use a molecular syringe to deliver effector proteins into the cytoplasm of host cells. These effectors target the host cell cytoskeleton, cell organelles and signaling pathways. This review addresses the multiple mechanisms by which the type III secretion system targets the intestinal immune response, with a special focus on pathogenic E. coli.

• Publication year

  2011

• Venue

  Journal of Inflammation

• Publication date

  2011-05-03

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1186/1476-9255-8-11PMID 21539730PMCID 3094202
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The assembly of a GTPase–kinase signalling complex by a bacterial catalytic scaffold

  2011cited by this paper
• Imbalance of NKp44[+]NKp46[-] and NKp44[-]NKp46[+] natural killer cells in the intestinal mucosa of patients with Crohn's disease

  2011cited by this paper
• A type III effector protease NleC from enteropathogenic Escherichia coli targets NF-κB for degradation

  2011cited by this paper
• Metalloprotease type III effectors that specifically cleave JNK and NF‐κB

  2011cited by this paper
• The sensing of environmental stimuli by follicular dendritic cells promotes immunoglobulin A generation in the gut.

  2010cited by this paper
• E. coli secreted protein F promotes EPEC invasion of intestinal epithelial cells via an SNX9‐dependent mechanism

  2010cited by this paper
• Intestinal Goblet Cells and Mucins in Health and Disease: Recent Insights and Progress

  2010cited by this paper
• The Type III Effectors NleE and NleB from Enteropathogenic E. coli and OspZ from Shigella Block Nuclear Translocation of NF-κB p65

  2010influential reference
• The Type III Secretion Effector NleE Inhibits NF-κB Activation

  2010cited by this paper
• Gamma Interferon Produced by Antigen-Specific CD4+ T Cells Regulates the Mucosal Immune Responses to Citrobacter rodentium Infection

  2010cited by this paper
• NleC, a Type III Secretion Protease, Compromises NF-κB Activation by Targeting p65/RelA

  2010cited by this paper
• Human-Restricted Bacterial Pathogens Block Shedding of Epithelial Cells by Stimulating Integrin Activation

  2010cited by this paper
• Activation of β-Catenin in Dendritic Cells Regulates Immunity Versus Tolerance in the Intestine

  2010cited by this paper
• The immune system and the gut microbiota: friends or foes?

  2010cited by this paper
• A new paradigm of bacteria-gut interplay brought through the study of Shigella

  2010cited by this paper
• Peyer's Patches: The Immune Sensors of the Intestine

  2010cited by this paper
• Pathogenic Bacteria Target NEDD8-Conjugated Cullins to Hijack Host-Cell Signaling Pathways

  2010cited by this paper
• A bacterial effector targets host DH‐PH domain RhoGEFs and antagonizes macrophage phagocytosis

  2010cited by this paper
• Proteasome-independent Degradation of Canonical NFκB Complex Components by the NleC Protein of Pathogenic Escherichia coli*

  2010cited by this paper
• The EspF Effector, a Bacterial Pathogen's Swiss Army Knife

  2010cited by this paper
• Inhibition of NF-κB Signaling in Human Dendritic Cells by the Enteropathogenic Escherichia coli Effector Protein NleE

  2010cited by this paper
• Bacterial interactions with the host epithelium.

  2010cited by this paper
• NleH effectors interact with Bax inhibitor-1 to block apoptosis during enteropathogenic Escherichia coli infection

  2010cited by this paper
• Enteropathogenic E. coli non‐LEE encoded effectors NleH1 and NleH2 attenuate NF‐κB activation

  2010cited by this paper
• The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors

  2010cited by this paper
• The pathogenic E. coli type III effector EspZ interacts with host CD98 and facilitates host cell prosurvival signalling

  2010cited by this paper
• The MAP kinase signaling cascades: a system of hundreds of components regulates a diverse array of physiological functions.

  2010cited by this paper
• Imbalance of NKp44(+)NKp46(-) and NKp44(-)NKp46(+) natural killer cells in the intestinal mucosa of patients with Crohn's disease.

  2010cited by this paper
• Faculty Opinions recommendation of Activation of beta-catenin in dendritic cells regulates immunity versus tolerance in the intestine.

  2010cited by this paper
• The Citrobacter rodentium Genome Sequence Reveals Convergent Evolution with Human Pathogenic Escherichia coli

  2009cited by this paper
• Gut Microbiota and Probiotics in Modulation of Epithelium and Gut-Associated Lymphoid Tissue Function

  2009influential reference
• Attaching and Effacing Escherichia coli Downregulate DNA Mismatch Repair Protein In Vitro and Are Associated with Colorectal Adenocarcinomas in Humans

  2009cited by this paper
• Co-evolution and exploitation of host cell signaling pathways by bacterial pathogens.

  2009cited by this paper
• Role of beta7 integrins in intestinal lymphocyte homing and retention.

  2009cited by this paper
• Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer.

  2009cited by this paper
• Bacteria hijack integrin-linked kinase to stabilize focal adhesions and block cell detachment

  2009influential reference
• Generation of Immunoglobulin diversity in human gut-associated lymphoid tissue.

  2009cited by this paper
• CXCR2-Dependent Mucosal Neutrophil Influx Protects against Colitis-Associated Diarrhea Caused by an Attaching/Effacing Lesion-Forming Bacterial Pathogen1

  2009cited by this paper
• A Comprehensive Proteomic Analysis of the Type III Secretome of Citrobacter rodentium*

  2009cited by this paper
• Bacterial Effector Binding to Ribosomal Protein S3 Subverts NF-κB Function

  2009influential reference
• A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity

  2009cited by this paper
• The role of neutrophils in the event of intestinal inflammation.

  2009cited by this paper
• The immune geography of IgA induction and function

  2008cited by this paper
• Bacterial cyclomodulin Cif blocks the host cell cycle by stabilizing the cyclin‐dependent kinase inhibitors p21waf1 and p27kip1

  2008cited by this paper
• EspJ of enteropathogenic and enterohaemorrhagic Escherichia coli inhibits opsono-phagocytosis

  2008cited by this paper
• Complete Genome Sequence and Comparative Genome Analysis of Enteropathogenic Escherichia coli O127:H6 Strain E2348/69

  2008cited by this paper
• Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense.

  2008cited by this paper
• Ribosomal protein S3: a KH domain subunit in NF-kappaB complexes that mediates selective gene regulation.

  2007cited by this paper
• Citrobacter rodentium virulence in mice associates with bacterial load and the type III effector NleE.

  2007cited by this paper
• The enteropathogenic E. coli effector EspB facilitates microvillus effacing and antiphagocytosis by inhibiting myosin function.

  2007cited by this paper
• The NleE/OspZ Family of Effector Proteins Is Required for Polymorphonuclear Transepithelial Migration, a Characteristic Shared by Enteropathogenic Escherichia coli and Shigella flexneri Infections

  2007cited by this paper
• Human CD8+ intraepithelial lymphocytes: a unique model to study the regulation of effector cytotoxic T lymphocytes in tissue

  2007cited by this paper
• Enteropathogenic Escherichia coli (EPEC) inactivate innate immune responses prior to compromising epithelial barrier function

  2007cited by this paper
• A bacterial effector targets Mad2L2, an APC inhibitor, to modulate host cell cycling.

  2007cited by this paper
• Translocation of enteropathogenic Escherichia coli across an in vitro M cell model is regulated by its type III secretion system

  2007cited by this paper
• Host–microbe interactions

  2007cited by this paper
• The enteropathogenic Escherichia coli EspF effector molecule inhibits PI‐3 kinase‐mediated uptake independently of mitochondrial targeting

  2006cited by this paper
• Balance of bacterial pro- and anti-inflammatory mediators dictates net effect of enteropathogenic Escherichia coli on intestinal epithelial cells.

  2006cited by this paper
• Bacterial genetic determinants of non-O157 STEC outbreaks and hemolytic-uremic syndrome after infection.

  2006influential reference
• An extensive repertoire of type III secretion effectors in Escherichia coli O157 and the role of lambdoid phages in their dissemination

  2006cited by this paper
• Essential Role of the Type III Secretion System Effector NleB in Colonization of Mice by Citrobacter rodentium

  2006cited by this paper
• Immunity, Inflammation, and Allergy in the Gut

  2005cited by this paper
• Enteropathogenic and Enterohemorrhagic Escherichia coli Infections: Translocation, Translocation, Translocation

  2005cited by this paper
• Characterization of Two Non-Locus of Enterocyte Effacement-Encoded Type III-Translocated Effectors, NleC and NleD, in Attaching and Effacing Pathogens

  2005cited by this paper
• Role of EspA and Intimin in Expression of Proinflammatory Cytokines from Enterocytes and Lymphocytes by Rabbit Enteropathogenic Escherichia coli-Infected Rabbits

  2005cited by this paper
• The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes.

  2005cited by this paper
• Expression and regulation of antimicrobial peptides in the gastrointestinal tract

  2004cited by this paper
• Dissecting virulence: systematic and functional analyses of a pathogenicity island.

  2004influential reference
• Enteropathogenic Escherichia coli Outer Membrane Proteins Induce iNOS by Activation of NF-κB and MAP Kinases

  2004cited by this paper
• Immune Regulation by helminth parasites: cellular and molecular mechanisms

  2003cited by this paper
• ADP ribosylation factor 6 is activated and controls membrane delivery during phagocytosis in macrophages

  2003cited by this paper
• Enteropathogenic and enterohaemorrhagic Escherichia coli deliver a novel effector called Cif, which blocks cell cycle G2/M transition

  2003cited by this paper
• Tissue Tropism of Enteropathogenic Escherichia coli Strains Belonging to the O55 Serogroup

  2002cited by this paper
• Enteropathogenic Escherichia coli mediates antiphagocytosis through the inhibition of PI 3‐kinase‐dependent pathways

  2001cited by this paper
• IgA responses in the intestinal mucosa against pathogenic and non-pathogenic microorganisms.

  2001cited by this paper
• Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

  2001cited by this paper
• Implication of Mitogen-Activated Protein Kinases in T84 Cell Responses to Enteropathogenic Escherichia coli Infection

  2001cited by this paper
• Collaboration of epithelial cells with organized mucosal lymphoid tissues

  2001influential reference
• Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria

  2001cited by this paper
• A Toll-like receptor recognizes bacterial DNA

  2000cited by this paper
• Intraepithelial lymphocytes: origins, distribution, and function.

  1998cited by this paper
• Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases.

  1998cited by this paper
• Trefoil peptides in the defense of the gastrointestinal tract.

  1997cited by this paper
• Immunophysiology of the gut: a research frontier for integrative studies of the common mucosal immune system.

  1993cited by this paper
• Enteropathogenic E. coli non-LEE encoded effectors NleH1 and NleH2 attenuate NF-kappa B activation

  year unknowninfluential reference

• Genetic and Virulence Characteristics of a Hybrid Atypical Enteropathogenic and Uropathogenic Escherichia coli (aEPEC/UPEC) Strain

  2020cites this paper
• Attaching and effacing pathogens: the effector abc of immune subversion.

  2020cites this paper
• A post-invasion role for Chlamydia type III effector TarP in modulating the dynamics and organization of host cell focal adhesions

  2020cites this paper
• Enteropathogenic Escherichia coli

  2019cites this paper
• The Unique Lifestyle of Crohn's Disease-Associated Adherent-Invasive Escherichia coli.

  2019cites this paper
• Diarrheagenic Escherichia coli Tânia

  2019cites this paper
• Molecular approaches in the diagnosis of diarrhoeal disease in children from rural Gambia

  2019cites this paper
• Enteropathogenic Escherichia coli

  2019cites this paper
• The Chlamydia type III effector TarP alters the dynamics and organization of host cell focal adhesions

  2018cites this paper
• Virulence gene profiles and molecular genetic characteristics of diarrheagenic Escherichia coli from a hospital in western China

  2018cites this paper
• iarrheagenic Escherichia coli ânia

  2017cites this paper
• Atypical enteropathogenic Escherichia coli as aetiologic agents of sporadic and outbreak-associated diarrhoea in Brazil.

  2016cites this paper
• Diarrheagenic Escherichia coli

  2016cites this paper
• Tight Junction Disruption Induced by Type 3 Secretion System Effectors Injected by Enteropathogenic and Enterohemorrhagic Escherichia coli

  2016cites this paper
• Atypical Enteropathogenic Escherichia coli

  2016cites this paper
• SZCZEPÓW ESCHERICHIA COLI – KLUCZOWA ROLA ADHEZJI

  2016cites this paper
• Haemorrhagic colitis associated with enterohaemorrhagic Escherichia coli O165 : H25 infection in a yearling feedlot heifer

  2015cites this paper
• Type III Secretion-Dependent Sensitivity of Escherichia coli O157 to Specific Ketolides

  2015cites this paper
• Prevalence of Enterohemorrhagic Escherichia coli O26, O45, O103, O111, O121, O145, and O157 on Hides and Preintervention Carcass Surfaces of Feedlot Cattle at Harvest

  2015cites this paper
• Systems analysis and characterization of mucosal immunity

  2015cites this paper
• Detection methods and intestinal adherence of non-O157 shiga toxin-producing Escherichia coli

  2015influential citation
• Distribution of non-LEE-encoded type 3 secretion system dependent effectors in enteropathogenic Escherichia coli

  2014cites this paper
• Type III secretion system-mediated immune modulation by enteropathogenic bacteria

  2014cites this paper
• Gut homeostasis in a microbial world: insights from Drosophila melanogaster

  2013cites this paper
• Effect of HIV and Chlamydia Infection on Rectal Inflammation and Cytokine Concentrations in Men Who Have Sex with Men

  2013cites this paper
• Unfolding Forces of NLeC , a Type III Secretion Protease

  2013cites this paper
• Animal models of enteroaggregative Escherichia coli infection

  2013cites this paper
• The Enteropathogenic Escherichia coli-Secreted Protein EspZ Inhibits Host Cell Apoptosis

  2012cites this paper
• Microbes and microbial effector molecules in treatment of inflammatory disorders

  2012influential citation
• Inflammation and Disintegration of Intestinal Villi in an Experimental Model for Vibrio parahaemolyticus-Induced Diarrhea

  2012cites this paper
• Analysis of O-island deletions in Escherichia coli O157:H7

  2012influential citation